Pediatric rheumatology in Africa: thriving amidst challenges.

BACKGROUND: Pediatric Rheumatology is an orphan specialty in Africa which is gradually gaining importance across the continent. MAIN BODY: This commentary discusses the current state of affairs in the sphere of Pediatric Rheumatology across Africa and offers practical strategies to navigate the challenges encountered in research, models of care, education and training. We outline the establishment, opportunities of growth and achievements of the Pediatric Society of the African League Against Rheumatism (PAFLAR).
CONCLUSION: This commentary lays the foundation for establishment of a formidable framework and development of partnerships for the prosperity of Pediatric Rheumatology in Africa and beyond.

Background

Africa is the second most populous continent in the world with an estimated 1.2 billion people and 496 million children [1, 2]. The pediatric population in Africa is postulated to rise to 661 million by 2030, becoming the continent with the most children [2]. There are approximately 6–7 million children afflicted worldwide with rheumatic disease and the majority of these, approximately 78%, live in Asia and Africa [3-5]. Rheumatic diseases often result in pain, disability, poor mental health and increased all-cause mortality [6]. Pediatric Rheumatic Diseases (PRDs) are perceived to be rare in Africa probably due to lack of local expertise and reporting [3-5]. In reality, there are significant numbers of children with rheumatic diseases in Africa who deserve care [3-5]. Acknowledging the burden of pediatric rheumatic diseases across Africa is an important critical step in providing care to these patients [7-15]. As we strive to achieve universal healthcare, non-communicable diseases such as PRDs require attention [16-18]. Developing the pediatric rheumatology workforce is a prerequisite to providing children with rheumatic diseases access to healthcare and good clinical outcomes [19]. Significant strides have been made to promote the discipline of Pediatric rheumatology in Africa as evidenced by the various centers that exist in the 10 of the 54 countries in Africa illustrated in Table 1 and Fig. 1. However much more still needs to be done to establish pediatric rheumatology services across the continent.

Table 1

Overview of Paediatric Rheumatology Centres in Africa

Country	Centre	Paediatric Rheumatologist	Contacts	Training Centre	Inpatients/year	Outpatient/year	Availability of Occupational Therapy/Physiotherapy	Availability of Synthetic DMARDs	Availability of Biological DMARDs
Northern Africa Region
1.Egypt	Abu el Reesh University Hospital	Hala M Lofty	Dr_hlofty@yahoo.com	Cairo University EULAR Courses	600	8000	Available	Available	Ant TNF Anti IL1 Anti IL6 Anti IL17 Anti IL23 JAK Inhibitors Anti CD 20
2.Libya	Benghazi Children Hospital	Halima Mohamed Benamer	benamer_h@yahoo,co.uk	Benghazi Children Hospital	50	300	Available	Available	Ant TNF Anti IL1 Anti IL6 Anti CD 20
	Tripoli Children’s Hospital	1.Soad Hashad 2.Hala Etayari 3.Eman Elmisllati-Traineee 4.Magda Tofil-Trainee 5.Zohairah Awhidah-Trainee 6.Aya Twati-Trainee	soadhashad@hotmail.com h.eltayari@uot.edu.ly dr.iman.misllati@gmail.com magdanaltfyl@gmail.com zohairah.awhaidah11@gmail.com	Tripoli Children’s Hospital Instituto Giannina Gaslini, Genoa/Italy EULAR Online Course	20	800
3.Tunisia	-Kassab Institute / Manouba -Mongi Slim Hospital Tunis -Children hospital Bechir Hamza / Tunis	Wafa HAMDI Leila Souabni Zohra Fitouri	wafahamdi6@yahoo.fr	Paris-Descartes University FRANCE	150	600	Available	Available	Anti TNF (5 molecules) Anti IL6 JAK Inhibitors Anti CD20 Anti IL17
4.Algeria	Batna 2 University	Djohra HADEF	djohra.hadef@paflar.org	France	30	100	Available	Available	Ant TNF Anti IL1 Anti IL6 Anti IL17 Anti CD 20
Eastern Africa Region
5.Kenya	Aga Khan University Medical College East Africa	Angela Migowa	angela.migowa@ paflar.org angela.migowa@aku.edu	McGill University Health Centre	30	200	Available	Available	Ant TNF Anti IL1 Anti IL6 JAK Inhibitors Anti CD 20
	University of Nairobi	Lawrence Owino	jahkaruoth2000@gmail.com	University of Cape Town	50	300
6.Tanzania	Dar es Salaam	Francis Fredrick	fredrick.francis78@gmail.com	EULAR Online Course University of Cape Town	50	300	Available	Available	Anti CD 20 Anti IL6
7.Sudan	Khartoum	Abubaker Fadlelmola	ytaha@doctors.org.uk	University of Cape Town	100	400	Available	Available	Inaccessible
		Yassmin Taha		United Kingdom
Western Africa Region
8.Nigeria	Lagos State University Teaching Hospital	Faleye Ayodele	faleyeayo2013@gmail.com	University of Cape Town	10–20	40			Anti TNF Anti CD 20
9.Ghana	Tamale	Yaninga Halwani Fusweni	yaninga@yahoo.com	University of Cape Town	6	5	Available	Available	Inaccessible
Southern Africa Region
10.South Africa	University of Cape Town	Chris Scott	chris.scott@uct.ac.za	South Africa and Belgium	450	1500	Available	Available	Ant TNF Anti IL1 Anti IL6 JAK Inhibitors Anti CD 20
		Kate Webb	drkatewebb@gmail.com	South Africa and UK
		Nicky Brice		University of Cape Town
		Waheba Slamang	waheba.slamang@gmail.com	University of Cape Town
		Deepthi Abraham	deepthi@sun.ac.za	Tygerberg Hospital	113	516
	Johannesburg	Gail Faller	gail.faller8@live.com	University of Witwatersrand	20–40	200
		Bhadrish Mistry	bjmistry@mweb.co.za	University of Western Australia	20–40	200
		Priya Ambaram	priya.ambaram@gmail.com	University of Witwatersrand	4–20	395
	Durban	Kogie Chinniah	chinniahk2@ukzn.ac.za	Nelson R Mandela School of Medicine	60	560

Fig. 1

African Countries with Pediatric Rheumatology Centres

The current state of pediatric rheumatology in Africa

A. Research

Epidemiological data concerning PRDs among children across Africa is scarce [20]. There are insufficient resources for research [21-23]. There is considerably less industry support in African countries [24, 25]. Studies from Africa are mostly hospital-based case series and may lack applicability to the community [26].

Despite the challenges, there are deliberate efforts to bridge the research gap in pediatric rheumatology across Africa [22-27]. Research has been carried out in the field of lupus and juvenile idiopathic arthritis among other rheumatic diseases [1, 11, 19–27]. It is imperative that we not only describe the disease phenotypes but aim to include our patients in biological research.

In Kenya and South Africa for example, there are nationwide collaborative studies on Multisystem Inflammatory Syndrome in Children (MIS-C) in order to describe the clinico-epidemiological characteristics and outcomes of MIS-C [28]. The African League Against Rheumatism (AFLAR) study on COVID-19 showed the benefits of pulling together both adult and pediatric rheumatologists to work on a common research agenda for the continent [29]. This is an indicator of the potential for more research collaborations among member countries of the AFLAR involving both pediatric and adult rheumatologists [29].

One of the key pillars in PAFLAR’s strategic plan is to build research by promoting collaborative efforts, establishment of registries, an ethical review board and a journal to showcase research from Africa. This shall be spearheaded by the existing PAFLAR Scientific Committee.

B. Models of Care

Telemedicine

There is a paucity of medical personnel across Africa with only 2.7 physicians per 10,000 people in Africa compared to 5.9 in South East Asia, 12.7 in the eastern Mediterranean, 15.5 in the Western Pacific, 21.5 in the Americas, and 32.1 in the European region [30]. Retention of trained specialists poses a challenge in Africa due to a lack of supportive frameworks and ‘brain drain’ [31]. This is challenging particularly when health systems are strained. Telemedicine offers a plausible solution [32]. Recently, there has been increased access to and reliance on remote meeting systems [33]. Tele-consults through platforms such as zoom can be used to enhance multi-disciplinary care for patients. Pediatric rheumatology teams in Nigeria and Kenya for example organize zoom meetings on a need to need basis to discuss and deliberate on patients they mutually have in common in a multi-disciplinary approach. Further research is required to explore how best to utilize telemedicine to promote pediatric rheumatology in Africa. In solidarity with global partners, researchers from Africa are participating in the validation of the virtual pediatric gait, arms, leg, spine (PGALS) screening examination as part of a global telemedicine initiative [33]. More research is needed to explore the feasibility of telemedicine for pediatric rheumatology in Africa.

C. Education and Training

I) PAFLAR Webinars

Since its establishment on September 7th, 2019, the Pediatric Society of the African League Against Rheumatism (PAFLAR) embarked on a series of webinars from the 5 regions of Africa i.e. northern, eastern, southern, central and western regions to help bridge the gap in pediatric rheumatology education. This has helped bring the pediatric rheumatology family in Africa much closer allowing exchange of knowledge where distance has been bridged by digital technology. This also serves as a platform to begin academic mentorship of pediatric trainees who log onto the webinars. In order to expand its reach, PAFLAR shall be collaborating with the Juvenile Inflammatory Rheumatism (JIR) winter school in Switzerland through facilitation of an ILAR grant to offer virtual conferences and webinars to members of both PAFLAR and JIR. The goal is to offer a blended learning experience by combining our PAFLAR webinars and the JIR rheumatology courses through fee subsidies to enrich the learning experience of pediatric rheumatologists and all other healthcare workers who care for pediatric rheumatology patients in the African continent while offering them an opportunity to showcase their clinical experience and expertise with the global rheumatology community.

II) Pediatric Rheumatology Training

There have been various initiatives to help bridge the gap in the pediatric rheumatology workforce [34-37]. This includes the UWEZO project, a collaboration between Kenyan, United Kingdom (UK) and Swedish rheumatologists who trained an estimated 500 physicians and health workers at 11 sites across Kenya [38]. The International League of Associations for Rheumatology (ILAR) supported onsite training in Zambia for 2 years under the EPAREP project (Enhancement of Pediatric and Adult Rheumatology Education and Practice) [39].

In early 2009, the International League of Associations for Rheumatology (ILAR) funded a program known as the “East Africa Initiative” in order to unite the international rheumatology community to promote rheumatology services in an area that carries 25% of the world’s disease burden but has only 2% of the world’s human resources for health [40]. Consequently, training for the only 2 pediatric rheumatologists in East and Central Africa, who are based in Kenya, was supported by rheumatology units in the United Kingdom (UK,) Canada and South Africa. Collaborations have spurred the growth of pediatric rheumatology in Africa through foundations such as “Rheumatology for All” with outreach activities in Ethiopia and Rwanda (https://rheumatologyforall.org).

Developing hybrid programs of local and international training, as occurs in Kuwait and Saudi Arabia, may be more feasible and sustainable [14, 15]. The Pediatric Rheumatology European Society (PReS) and other bodies may look to set up “sister hospital initiatives” where “areas of need” partner with well-resourced hospitals to provide education and clinical support. A similar initiative was successfully undertaken as part of the southern hemisphere educational partnership for pediatric arthritis and rheumatological diseases (SHEPPARD) program between Argentina and South Africa [34]. These kinds of activities happen informally all the time, but a centralized or regional system would enable people to access them more easily.

Conclusion

This is a long journey which has already started and is gaining momentum. Initiatives such as the creation of a Pediatric Society of the African League Against Rheumatism (PAFLAR), the creation of Global Task Force for Musculoskeletal Health and PReS (Pediatric Rheumatology European Society) initiatives indicate that a core group of rheumatology health care providers and indeed the global community, have recognized that reaching out to the millions of children who live with rheumatic diseases in areas or situations where appropriate care is unavailable or inaccessible is a moral imperative.